The same PI for two studies in the same time [Study As­sess­ment]

posted by Ohlbe – France, 2020-01-06 11:27 (416 d 14:09 ago) – Posting: # 21060
Views: 1,882

Dear Osama,

» I think the risk of Mixing up is high when the PI and his/her clinical team are involved in both studies at the same time, think about adverse events which could be happened and his/her responsibility for the protection of study subjects, Mixing up in the collection of subjects study samples , ....etc

Not to mention ethical concerns, with the fasting subjects smelling the breakfast eaten by the fed subjects ;-)

More seriously: it really depends on how the CRO is set up. Many CROs have several, clearly separated clinics within the same building, which can operate totally independently. No difference from trials being run separately in time.

Having both trials being performed in the same room would indeed be at high risk, but not necessarily higher than having two trials on different drugs for different sponsors.

» » In some countries the PI is purely an administrative matter; she or he will not see the subjects/patients but have everything delegated.
»
» I know that in some very rare cases that the PI has purely an administrative job, but mostly he/she is a physician who do practically the clinical part from A to Z.

Again, in my experience it varies widely from one CRO to the next. Some CROs will appoint as principal investigator the most senior MD of the CRO, who will delegate most practical activities to sub-investigators.

Regards
Ohlbe

Complete thread:

Activity
 Admin contact
21,356 posts in 4,458 threads, 1,493 registered users;
online 2 (0 registered, 2 guests [including 1 identified bots]).
Forum time: Friday 01:36 UTC (Europe/Vienna)

Those who make no mistakes are making the biggest mistakes of all 
they are attempting nothing new.    Anthony de Mello

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5